
American virologist Judy Mikovits conceded in 2012 that there was no evidence that XMRV was a human pathogen.
As per the AABB's publication about XMRV, it originated from the recombination of two mouse endogenous retroviruses during the passing of a prostate tumour xenograft (CWR22) in mice, generating laboratory-derived cell lines that were XMRV-infected. There is no valid evidence that XMRV infect humans or are associated with human disease.
A similar conclusion has been arrived upon in the publication by Clinical Microbiology Reviews.
Copied!